Cargando…
The European Innovative Medicines Initiative: Progress to Date
The Innovative Medicines Initiative is a public–private partnership between the European Union and the pharmaceuticals industry that was established in 2008, with an overall budget of €5.3 billion from 2008 until 2024. The objective of the initiative is to boost pharmaceutical innovation in Europe a...
Autores principales: | Faure, Jean-Emmanuel, Dyląg, Tomasz, Norstedt, Irene, Matthiessen, Line |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105180/ https://www.ncbi.nlm.nih.gov/pubmed/30174434 http://dx.doi.org/10.1007/s40290-018-0241-y |
Ejemplares similares
-
Targeting the Serotonin 5-HT(7) Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
por: Nikiforuk, Agnieszka
Publicado: (2015) -
Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome: Progress to Date
por: Chang, Zhijie, et al.
Publicado: (2012) -
The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children
por: Turner, Mark A., et al.
Publicado: (2021) -
A European CDC
por: The Lancet Infectious Diseases
Publicado: (2003) -
The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation
por: Callréus, Torbjörn
Publicado: (2022)